1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Glomerulonephritis, Membranous in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aiello, S; Benfenati, E; Benigni, A; Boccardo, P; Gotti, E; Noris, M; Remuzzi, G; Todeschini, M | 1 |
Horie, M; Mase, T; Nagaoka, H; Sakurai, Y; Tomioka, K; Yamada, T | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Glomerulonephritis, Membranous
Article | Year |
---|---|
Urinary excretion of platelet activating factor in patients with immune-mediated glomerulonephritis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Female; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; Neutrophils; Phospholipases A; Platelet Activating Factor; Proteinuria | 1993 |
Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat.
Topics: Animals; Azepines; Disease Models, Animal; Glomerulonephritis, Membranous; Hypercholesterolemia; Male; Metabolic Clearance Rate; Methylprednisolone; Piperazines; Platelet Activating Factor; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines; Ticlopidine; Triazoles | 1991 |